Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 2, 2016 at 10:05 AM EDT

Top 6 Biopharma Gainers of the Past Week

Over the past week, a few biotech companies made absolutely massive runs. The companies 24/7 Wall St. has picked stood…

Chris Lange | Sep 30, 2016 at 9:10 AM EDT

SEC Issues Charges Over Biotech Insider Activity

The SEC has charged the former senior director of regulatory affairs for Puma Biotechnology with insider trading ahead of the…

Lee Jackson | Sep 30, 2016 at 8:25 AM EDT

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less…

Chris Lange | Sep 29, 2016 at 12:40 PM EDT

Catabasis Skyrockets on Sarepta Partnership

Catabasis Pharmaceuticals shares skyrocketed on Thursday following an announcement that it would be partnering with Sarepta Therapeutics for a joint…

Jon C. Ogg | Sep 29, 2016 at 12:10 PM EDT

2 Animal Health Stocks Still Look Attractive for Investors

If there is one trend that has worked in America, it is the trend of betting on the public taking…

Chris Lange | Sep 29, 2016 at 12:05 PM EDT

Alcobra Tumbles on FDA Clinical Hold

Alcobra saw its shares get halved on Thursday after the U.S. Food and Drug Administration (FDA) placed a clinical hold…

Jon C. Ogg | Sep 29, 2016 at 11:45 AM EDT

Mylan Woes Pushing Stock Back Toward 52-Week Low

Mylan just has been unable to recover from its EpiPen pricing hike issue. Thursday's additional weakness was tied to a…

Chris Lange | Sep 29, 2016 at 10:45 AM EDT

Genocea Biosciences Posts Positive Herpes Trial Results

Shares of Genocea Biosciences saw a handy gain early on Thursday on positive news from its genital herpes trial, but…

Chris Lange | Sep 29, 2016 at 9:55 AM EDT

Intra-Cellular Stumbles Over Late-Stage Results

Intra-Cellular Therapies saw its shares absolutely crash on Thursday following the results from its late-stage schizophrenia trial.

Chris Lange | Sep 28, 2016 at 11:15 AM EDT

Anavex Soars on Biogen Agreement

Shares of Anavex Life Sciences soared on Wednesday following a material transfer agreement with Biogen.

Lee Jackson | Sep 28, 2016 at 10:35 AM EDT

Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week

In a Jefferies research report, the top growth stock picks for this week are littered with outstanding biotech companies that…

Douglas A. McIntyre | Sep 28, 2016 at 9:00 AM EDT

Aetna to Give Away iPhones

Health insurance giant Aetna will start to give away iPhones, iPads and Apple Watches as part of an experiment. But…

Chris Lange | Sep 27, 2016 at 10:20 AM EDT

Tabula Rasa Healthcare Updates Expected IPO Pricing

Tabula Rasa Healthcare intends to price more than 4 million shares in the range of $13 to $15 per share…

Chris Lange | Sep 27, 2016 at 9:15 AM EDT

Fulgent Genetics Announces Potential Pricing for IPO

Fulgent Genetics expects to offer more than 4 million shares in an expected price range of $12 to $14 per…

Chris Lange | Sep 27, 2016 at 7:50 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest moves were upward across…

1 … 192 193 194 195 196 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Top 6 Biopharma Gainers of the Past Week

SEC Issues Charges Over Biotech Insider Activity

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Catabasis Skyrockets on Sarepta Partnership

2 Animal Health Stocks Still Look Attractive for Investors

Alcobra Tumbles on FDA Clinical Hold

Mylan Woes Pushing Stock Back Toward 52-Week Low

Genocea Biosciences Posts Positive Herpes Trial Results

Intra-Cellular Stumbles Over Late-Stage Results

Anavex Soars on Biogen Agreement

Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week

Aetna to Give Away iPhones

Tabula Rasa Healthcare Updates Expected IPO Pricing

Fulgent Genetics Announces Potential Pricing for IPO

Short Sellers Increase Bets in Major Biotechs

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Health and Healthcare Articles

All Health and Healthcare Articles

Top 6 Biopharma Gainers of the Past Week

SEC Issues Charges Over Biotech Insider Activity

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Catabasis Skyrockets on Sarepta Partnership

2 Animal Health Stocks Still Look Attractive for Investors

Alcobra Tumbles on FDA Clinical Hold

Mylan Woes Pushing Stock Back Toward 52-Week Low

Genocea Biosciences Posts Positive Herpes Trial Results

Intra-Cellular Stumbles Over Late-Stage Results

Anavex Soars on Biogen Agreement

Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week

Aetna to Give Away iPhones

Tabula Rasa Healthcare Updates Expected IPO Pricing

Fulgent Genetics Announces Potential Pricing for IPO

Short Sellers Increase Bets in Major Biotechs

IAU Returned 42% in a Year of Sticky Inflation. Here’s Why Allocators Are Reconsidering Gold

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check